System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Ithaar Derweesh, MD is an expert in Urology at Rush University Medical Center (United States). As of October 2026, ScienceLeadR ranks Ithaar Derweesh in the top 1% of experts worldwide for Kidney Neoplasms, Urologic Neoplasms and Carcinoma. Ithaar Derweesh has authored 702 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 2,418 (community average: 125). How the SLR is computed.

LeadR Profile

Ithaar Derweesh, MD Rush University Medical Center United States
2 418 ScienceLeadR Reputation 2418

Unlock

Register Login
Network Map

Urology

Subspecialties: Oncology - Nephrology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2001 - 2026
Source: PubMed

Rush University Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 702

Citations

Citations: 13 618 1st author: 31 Last author: 325 Unique author: 14

Main journals

J Urol 249
J Clin Oncol 58
Eur Urol 55
Urol Oncol 41
BJU Int 37

Best Journals

J Clin Oncol 45

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Global guidelines for the management of penile cancer: evaluating clinical alignment and methodological rigor.
PMID 42823862 — penile neoplasms, lymph nodes, neoplasms, lymph, therapeutics		Minerva Urol Nephrol20260
Oncological outcomes of radical nephroureterectomy with or without lymphadenectomy and neoadjuvant therapy in cN+ UTUC: Insights from the ROBUUST registry.
PMID 42570349 — registries, lymph node excision, neoplasms, neoadjuvant therapy, therapeutics, medical oncology, nephroureterectomy		Eur J Surg Oncol20260
External validation of the preoperative risk evaluation for partial nephrectomy (PREP) score.
PMID 42415951 — multiple chronic conditions, nephrectomy, pulmonary disease, chronic obstructive		BJUI Compass20260
Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis.
PMID 42346227 — mortality, c-reactive protein, neoplasms, nephrectomy, biopsy, survival analysis, algorithms, histology		Curr Oncol20260
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registry.
PMID 42329063 — registries, urinary bladder, urinary bladder neoplasms, glomerular filtration rate, incidence, neoplasms, multiple chronic conditions		Urol Pract20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
NCT05363657 — registries, cells, ablation techniques, neoplasms, nephrectomy, kidney, carcinoma, renal cell, cryosurgery, kidney neoplasms, records, therapeutics, surgeons, carcinoma		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS